What is hepb.org?
Operating as a premier global non-profit, the Hepatitis B Foundation occupies a unique position at the intersection of medical research and patient advocacy. The organization provides an essential infrastructure for those affected by hepatitis B, offering a centralized repository of resources that includes drug watch programs, clinical trial facilitation, and specialized training for healthcare professionals. By bridging the gap between complex medical data and actionable patient care, the foundation effectively manages a multi-faceted approach to disease prevention and management. Its market position is defined by its ability to mobilize resources for high-impact research while simultaneously influencing public health policy to improve long-term outcomes for diverse patient populations worldwide.
How much funding has hepb.org raised?
hepb.org has raised a total of $177K across 1 funding round:
Debt
$177K
Debt (2021): $177K with participation from PPP
Key Investors in hepb.org
PPP
Public-Private Partnership
What's next for hepb.org?
With the infusion of this latest capital, the Hepatitis B Foundation is strategically positioned to scale its research and advocacy operations. The organization is expected to prioritize the development of novel therapeutic pathways and the expansion of its digital education platforms, which are vital for reaching underserved communities. As the foundation enters this new phase of growth, the focus will likely shift toward enhancing the efficacy of clinical trial recruitment and deepening its engagement with global health stakeholders. By maintaining a disciplined approach to resource allocation, the foundation aims to solidify its leadership in the fight against hepatitis B, ultimately driving toward the long-term goal of a universal cure.
See full hepb.org company page
